Research in plasma proteomics is yielding new biological insights and potential biomarkers for various conditions. Studies are exploring the use of plasma proteomics to diagnose and predict outcomes for diseases, including vasculitis and those treated with radiotherapy. Advances in technology and analysis are driving these developments, with companies also making strategic moves to expand their presence in the field.